Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

BETHESDA, Md., Dec. 04, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today...

Related Keywords

John Vandermosten ,Matthias Alder ,Susan Sharpe ,Linnden Communications ,Gain Therapeutics Inc ,Linkedin ,Family Office ,Nasdaq ,Cap Research ,Chief Executive Officer ,Senior Analyst ,Zacks Small Cap Research ,Gain Therapeutics ,Media Contact ,Markets ,